All tagged hydroxychloroquine study

Michigan hospital study shows hydroxychloroquine cut death rates by half

Michigan hospital study shows hydroxychloroquine cut death rates by half

Tatiana Prophet
Covid-19

A retrospective, peer-reviewed study by the Henry Ford Health System in Detroit found that hospitalized Covid-19 patients who received the anti-malaria drug hydroxychloroquine early in their stay were half as likely to die as the control group, the nonprofit hospital announced Thursday. The study’s author, Dr. Marcus Zervos, attributed the results to the timing of patients receiving HCQ.

The Ford press release stated:

“In a large-scale retrospective analysis of 2,541 patients hospitalized between March 10 and May 2, 2020, across the system’s six hospitals, the study found 13% of those treated with hydroxychloroquine alone died compared to 26.4% not treated with hydroxychloroquine. None of the patients had documented serious heart abnormalities; however, patients were monitored for a heart condition routinely pointed to as a reason to avoid the drug as a treatment for COVID-19.”

Zinc/Z-pack and HCQ show promise in NYU study

Zinc/Z-pack and HCQ show promise in NYU study

Tatiana Prophet
Health

An NYU study that involved 100 mg of zinc sulfate added to hydroxychloroquine, shows that people given that combo, with azithromycin, are 45 percent less likely to die from Covid-19, 46 percent less likely to be transferred to intensive care, and 38 percent likely to be put on a ventilator. But once a patient is transferred to intensive care, the odds of survival go way down even with the HCQ cocktail.

Read all about it.

Spectrum's 24-hour New York City cable channel, NY-1, has been one of the few outlets following hydroxychloroquine (two articles so far on the Langone trials). And more studies will be coming out of NYU — including double-blind and randomized, as well as the University of South Dakota, and Cedars-Sinai in Los Angeles.